Parkinson's Rehab and Management-Evidence-Based Update

Course overview

Parkinson's disease represents one of the most significant neurological challenges of our time, affecting approximately 10 million individuals worldwide and imposing substantial burdens on patients, families, and healthcare systems. As the second most common neurodegenerative disorder after Alzheimer's disease, Parkinson's disease presents a complex constellation of motor and non-motor symptoms that progressively impair functional independence, quality of life, and participation in meaningful activities. The cardinal motor features of bradykinesia, rigidity, tremor, and postural instability are accompanied by an equally debilitating array of non-motor manifestations including cognitive impairment, mood disorders, sleep disturbances, autonomic dysfunction, and fatigue. This multifaceted symptom burden demands a comprehensive, coordinated approach to care that extends far beyond pharmacological management alone. The epidemiological landscape of Parkinson's disease continues to evolve, with prevalence rates increasing as populations age and diagnostic capabilities improve. Current estimates suggest that Parkinson's disease affects approximately 1 to 2 percent of individuals over age 60, with incidence rates rising steeply after age 65. Young-onset Parkinson's disease, defined as symptom onset before age 50, accounts for approximately 10 percent of cases and presents unique challenges related to employment, family responsibilities, and the prolonged disease trajectory these individuals face. Geographic and demographic variations in disease prevalence highlight the importance of understanding both genetic and environmental risk factors, while also underscoring global disparities in access to specialized care and rehabilitation services. The landscape of Parkinson's disease rehabilitation has undergone remarkable transformation in recent years, driven by an expanding evidence base that firmly establishes the efficacy of physical therapy, occupational therapy, and nursing interventions across all disease stages. Contemporary clinical practice guidelines from the American Physical Therapy Association and international consensus statements now provide clear, actionable recommendations for rehabilitation professionals, emphasizing the critical importance of early referral, stage-specific intervention, and sustained engagement in physical activity. The emergence of specialized multidisciplinary care networks, telerehabilitation platforms, and technology-enabled interventions has further expanded the therapeutic armamentarium available to clinicians while addressing longstanding barriers to access and adherence. This continuing education course provides rehabilitation and healthcare professionals with a comprehensive, evidence-based update on current best practices in Parkinson's disease management. Drawing upon the most recent systematic reviews, meta-analyses, randomized controlled trials, and clinical practice guidelines published between 2022 and 2025, this course synthesizes the latest evidence regarding exercise prescription, external cueing strategies, occupational therapy interventions, multidisciplinary care models, and emerging technology-enabled approaches. Particular attention is devoted to the practical implementation of evidence-based interventions across care settings, from outpatient and community-based programs to intensive inpatient rehabilitation and home-based telehealth models. The course is structured to address the full continuum of Parkinson's disease care, from early-stage management focused on maintaining function and preventing decline, through mid-stage interventions targeting gait impairment and fall prevention, to advanced-stage rehabilitation emphasizing safety, quality of life, and palliative considerations. Throughout, the unique and complementary contributions of physical therapy, occupational therapy, and nursing are emphasized within the context of integrated, patient-centered care. Six comprehensive ca